AAAAAA

   
Results: 1-21 |
Results: 21
ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) FOR EARLY BREAST-CANCER - 13 YEARS UPDATE OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) FOR EARLY BREAST-CANCER - 13 YEARS UPDATE OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 102-102
RADIOSENSITIZATION OF MOUSE SARCOMA-CELLS BY FLUDARABINE (F-ARA-A) ORGEMCITABINE (DFDC), 2 NUCLEOSIDE ANALOGS, IS NOT MEDIATED BY AN INCREASED INDUCTION OR A REPAIR INHIBITION OF DNA DOUBLE-STRAND BREAKS AS MEASURED BY PULSED-FIELD GEL-ELECTROPHORESIS
Authors: GREGOIRE V BEAUDUIN M BRUNIAUX M DECOSTER B PRIGNOT MO SCALLIET P
Citation: V. Gregoire et al., RADIOSENSITIZATION OF MOUSE SARCOMA-CELLS BY FLUDARABINE (F-ARA-A) ORGEMCITABINE (DFDC), 2 NUCLEOSIDE ANALOGS, IS NOT MEDIATED BY AN INCREASED INDUCTION OR A REPAIR INHIBITION OF DNA DOUBLE-STRAND BREAKS AS MEASURED BY PULSED-FIELD GEL-ELECTROPHORESIS, International journal of radiation biology, 73(5), 1998, pp. 511-520
A DOUBLE RANDOMIZED TRIAL ON PORTAL AND SYSTEMIC CHEMOTHERAPY FOR DUKES B2 AND C COLORECTAL-CANCER - A 3 YEARS REPORT ON A DOUBLE RANDOMIZED TRIAL
Authors: FOCAN C BURY J BEAUDUIN M HERMAN ML VINDEVOGHEL A LECOMTE M BROHEE D CANON JL
Citation: C. Focan et al., A DOUBLE RANDOMIZED TRIAL ON PORTAL AND SYSTEMIC CHEMOTHERAPY FOR DUKES B2 AND C COLORECTAL-CANCER - A 3 YEARS REPORT ON A DOUBLE RANDOMIZED TRIAL, Annals of oncology, 9, 1998, pp. 159-159
KINETICS OF MOUSE JEJUNUM RADIOSENSITIZATION BY 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AND ITS RELATIONSHIP WITH PHARMACODYNAMICS OF DNA-SYNTHESIS INHIBITION AND CELL-CYCLE REDISTRIBUTION IN CRYPT CELLS (VOL 76, PG 1315, 1997)
Authors: GREGOIRE V BEAUDUIN M ROSIER JF DECOSTER B BRUIAUX M OCTAVEPRIGNOT M SCALLIET P
Citation: V. Gregoire et al., KINETICS OF MOUSE JEJUNUM RADIOSENSITIZATION BY 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AND ITS RELATIONSHIP WITH PHARMACODYNAMICS OF DNA-SYNTHESIS INHIBITION AND CELL-CYCLE REDISTRIBUTION IN CRYPT CELLS (VOL 76, PG 1315, 1997), British Journal of Cancer, 77(6), 1998, pp. 1026-1026
THE ROLE OF GEMCITABINE-INDUCED CELL-CYCLE SYNCHRONIZATION IN RADIOSENSITIZATION OF A-SCC61 HUMAN HEAD AND NECK SQUAMOUS CARCINOMA CELL (HNSCC) LINE
Authors: ROSIER JF BEAUDUIN M BRUNIAUX M DECOSTER B DEBAST M SCALLIET P GREGOIRE V
Citation: Jf. Rosier et al., THE ROLE OF GEMCITABINE-INDUCED CELL-CYCLE SYNCHRONIZATION IN RADIOSENSITIZATION OF A-SCC61 HUMAN HEAD AND NECK SQUAMOUS CARCINOMA CELL (HNSCC) LINE, European journal of cancer, 33, 1997, pp. 89-89
PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER
Authors: CATY A OUDARD S HUMBLET Y BEAUDUIN M SUC E GIL T ROLLAND F HOUYAU P SUN X MONTCUQUET P BREZA J FAVREAU E TRESCA P CHOPIN D
Citation: A. Caty et al., PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, European journal of cancer, 33, 1997, pp. 135-135
KINETICS OF MOUSE JEJUNUM RADIOSENSITIZATION BY 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AND ITS RELATIONSHIP WITH PHARMACODYNAMICS OF DNA-SYNTHESIS INHIBITION AND CELL-CYCLE REDISTRIBUTION IN CRYPT CELLS
Authors: GREGOIRE V BEAUDUIN M ROSIER JF DECOSTER B BRUNIAUX M OCTAVEPRIGNOT M SCALLIET P
Citation: V. Gregoire et al., KINETICS OF MOUSE JEJUNUM RADIOSENSITIZATION BY 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AND ITS RELATIONSHIP WITH PHARMACODYNAMICS OF DNA-SYNTHESIS INHIBITION AND CELL-CYCLE REDISTRIBUTION IN CRYPT CELLS, British Journal of Cancer, 76(10), 1997, pp. 1315-1321
AUTONOMOUS THYROID ADENOMA - USEFULNESS O F THALLIUM SCINTIGRAPHY ANDHISTOLOGY
Authors: VANESPEN MB HERMANS J BODART F SCHMITZ A FRANCOIS D BEAUDUIN M
Citation: Mb. Vanespen et al., AUTONOMOUS THYROID ADENOMA - USEFULNESS O F THALLIUM SCINTIGRAPHY ANDHISTOLOGY, Annales d'Endocrinologie, 58(6), 1997, pp. 482-493
CLINICAL-EVIDENCE FOR AN ENGRAFTMENT SYNDROME-ASSOCIATED WITH EARLY AND STEEP NEUTROPHIL RECOVERY AFTER AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION
Authors: RAVOET C FEREMANS W HUSSON B MAJOIS F KENTOS A LAMBERMONT M WALLEF G CAPEL P BEAUDUIN M DELANNOY A
Citation: C. Ravoet et al., CLINICAL-EVIDENCE FOR AN ENGRAFTMENT SYNDROME-ASSOCIATED WITH EARLY AND STEEP NEUTROPHIL RECOVERY AFTER AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 18(5), 1996, pp. 943-947
ASSESSMENT OF COLORECTAL-CANCER RECURRENCE USING WHOLE-BODY PET-FDG
Authors: LONNEUX M BAUSART R SIBOMANA M DETRY R BEAUDUIN M JAMAR F PAUWELS S
Citation: M. Lonneux et al., ASSESSMENT OF COLORECTAL-CANCER RECURRENCE USING WHOLE-BODY PET-FDG, The Journal of nuclear medicine, 37(5), 1996, pp. 1155-1155
UNEXPECTED OPPOSITE AGE-RELATED EFFECT OF ADJUVANT HIGH-DOSE PROGESTERONE ACETATE (HD-MPA) FOR NODE-POSITIVE (NP) EARLY BREAST-CANCER - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., UNEXPECTED OPPOSITE AGE-RELATED EFFECT OF ADJUVANT HIGH-DOSE PROGESTERONE ACETATE (HD-MPA) FOR NODE-POSITIVE (NP) EARLY BREAST-CANCER - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 46-46
IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 56-56
LEVAMISOLE ADDS GRANULOCYTE TOXICITY TO 5FU-BASED CHEMOTHERAPIES IN ADJUVANT TREATMENT OF DUKES B-C COLORECTAL-CANCER - A PRELIMINARY-REPORT
Authors: LONGREE L FOCAN C BURY J BEAUDUIN M BROHEE D DUVIVIER A LECOMTE M MARKIEWICZ S VINDEVOGHEL A WEERTS J
Citation: L. Longree et al., LEVAMISOLE ADDS GRANULOCYTE TOXICITY TO 5FU-BASED CHEMOTHERAPIES IN ADJUVANT TREATMENT OF DUKES B-C COLORECTAL-CANCER - A PRELIMINARY-REPORT, Anticancer research, 15(4), 1995, pp. 1561-1564
EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA
Authors: BRASSEUR F RIMOLDI D LIENARD D LETHE B CARREL S ARIENTI F SUTER L VANWIJCK R BOURLOND A HUMBLET Y VACCA A CONESE M LAHAYE T DEGIOVANNI G DERAEMAECKER R BEAUDUIN M SASTRE X SALAMON E DRENO B JAGER E KNUTH A CHEVREAU C SUCIU S LACHAPELLE JM POUILLART P PARMIANI G LEJEUNE F CEROTTINI JC BOON T MARCHAND M
Citation: F. Brasseur et al., EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA, International journal of cancer, 63(3), 1995, pp. 375-380
SCREENING FOR INFRACLINICAL HYPOTHYROIDIS M WITH THE TRH TEST AND ANTI-TPO ANTIBODY-ASSAY
Authors: HERMANS J WADELEUX P BODART F BEAUDUIN M
Citation: J. Hermans et al., SCREENING FOR INFRACLINICAL HYPOTHYROIDIS M WITH THE TRH TEST AND ANTI-TPO ANTIBODY-ASSAY, Annales d'Endocrinologie, 56(3), 1995, pp. 219-224
IS THERE POTENTIAL FOR GRANULOCYTE OR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS IN RADIOTHERAPY
Authors: JANSSENS P MITINE C BEAUDUIN M SCALLIET P
Citation: P. Janssens et al., IS THERE POTENTIAL FOR GRANULOCYTE OR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS IN RADIOTHERAPY, European journal of cancer, 30A(5), 1994, pp. 642-645
PREVENTION OF ADJUSTMENT DISORDERS AND ANTICIPATORY NAUSEA SECONDARY TO ADJUVANT CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE USEFULNESS OF ALPRAZOLAM
Authors: RAZAVI D DELVAUX N FARVACQUES C DEBRIER F VANHEER C KAUFMAN L DERDE MP BEAUDUIN M PICCART M
Citation: D. Razavi et al., PREVENTION OF ADJUSTMENT DISORDERS AND ANTICIPATORY NAUSEA SECONDARY TO ADJUVANT CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE USEFULNESS OF ALPRAZOLAM, Journal of clinical oncology, 11(7), 1993, pp. 1384-1390
DOSE-DEPENDENT INTERLEUKIN-3 STIMULATION OF THROMBOPOIESIS AND NEUTROPOIESIS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA BEFORE AND FOLLOWING CHEMOTHERAPY - A PLACEBO-CONTROLLED RANDOMIZED PHASE-IB STUDY
Authors: DHONDT V WEYNANTS P HUMBLET Y GUILLAUME T CANON JL BEAUDUIN M DUPREZ P LONGUEVILLE J MULL R CHATELAIN C SYMANN M
Citation: V. Dhondt et al., DOSE-DEPENDENT INTERLEUKIN-3 STIMULATION OF THROMBOPOIESIS AND NEUTROPOIESIS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA BEFORE AND FOLLOWING CHEMOTHERAPY - A PLACEBO-CONTROLLED RANDOMIZED PHASE-IB STUDY, Journal of clinical oncology, 11(11), 1993, pp. 2063-2071
CLONAL REARRANGEMENT OF THE T-CELL RECEPTOR BETA-CHAIN GENE IN THE PLEURAL FLUID OF A PATIENT WITH THYMOMA
Authors: DELANNOY A PHILIPPE M HAMELS J BEAUDUIN M
Citation: A. Delannoy et al., CLONAL REARRANGEMENT OF THE T-CELL RECEPTOR BETA-CHAIN GENE IN THE PLEURAL FLUID OF A PATIENT WITH THYMOMA, Nouvelle revue francaise d'hematologie, 35(2), 1993, pp. 121-124
CAN BENIGN AND MALIGNANT THYROID-NODULES BE DIFFERENTIATED WITH THALLIUM-201
Authors: HERMANS J SCHMITZ A MERLO P BODART F BEAUDUIN M
Citation: J. Hermans et al., CAN BENIGN AND MALIGNANT THYROID-NODULES BE DIFFERENTIATED WITH THALLIUM-201, Annales d'Endocrinologie, 54(4), 1993, pp. 248-254
THYROPEROXYDASE ANTIBODY-ASSAY IN COMMON THYROID PATHOLOGY - CLINICALAND METHODOLOGICAL APPROACH
Authors: HAMBYE AS HERMANS J WADELEUX P BEZY F BODART F BEAUDUIN M
Citation: As. Hambye et al., THYROPEROXYDASE ANTIBODY-ASSAY IN COMMON THYROID PATHOLOGY - CLINICALAND METHODOLOGICAL APPROACH, Annales d'Endocrinologie, 54(3), 1993, pp. 181-189
Risultati: 1-21 |